The respiratory inhaler devices market is a critical component of the global healthcare industry, focusing on devices designed to deliver medication directly to the lungs to treat respiratory diseases ...

Lupin is now utilizing Honeywell’s Solstice Air in its respiratory inhalers, significantly improving respiratory care with propellants that have near-zero global warming potential. This ...

The industry is anticipated to reach USD 29,329.2 million by 2034. The respiratory inhaler devices market is a critical component of the global healthcare industry, focusing on devices designed to ...

Inhalers are important for health, but some types (aerosol inhalers, sometimes called 'puffers'), contain a greenhouse gas which is much more powerful than carbon dioxide. These inhalers are safe ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...

Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

They're produced by an industry-leading manufacturer, but one U.S. agency warns of a defect concerning this well known inhaler prescription. Wildfire events have become an all-too-common occurrence in ...

OTC asthma inhalers are typically not recommended as a replacement for prescription asthma treatment. They are generally considered viable only for treating mild, intermittent asthma , and they ...